+454.2%
MRNA vs GD
+11.5%
+442.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.1% | -2.3% | -2.7% |
| 7D | -10.1% | -3.1% | -6.9% | -8.3% |
| 30D | +126.7% | -10.9% | +137.7% | +143.7% |
| 3M | +184.1% | +2.5% | +181.6% | +174.2% |
| 6M | +143.3% | -1.7% | +145.0% | +150.4% |
| YTD | +359.9% | +6.1% | +353.7% | +327.0% |
| 1Y | +454.2% | +11.7% | +442.5% | +410.5% |
| All | +454.2% | +11.5% | +442.7% | +410.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GD.
Daily Out/Under-Performance
Portfolio return minus GD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling